Study tracks virus shedding in COVID-19 contacts
NCT ID NCT04259892
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study followed 324 people who had close contact with a confirmed COVID-19 case to see how long they shed the virus. Participants provided nasal swabs and reported symptoms over 12 days. The goal was to understand transmission risks and help shape public health policies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could clarify how long and how often exposed individuals spread the virus, informing better quarantine guidelines.
- What could go wrong
- This is an observational study, not a treatment trial. Results may not apply to later variants or different populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord
Saint-Denis, 97400, France
-
Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau
Tours, 37000, France
-
Centre Investigation Clinique 1417 Hôpital Cochin Bâtiment Lavoisier
Paris, 75679, France
-
Centre Investigation Clinique 1433 CHRU de NANCY
Nancy, 54511, France
-
Centre d'Investigation Clinique 1403 -CHU Lille
Lille, 59037, France
-
Centre d'Investigation Clinique Hôpital Saint Louis
Paris, 75010, France
-
Centre d'Investigation Clinique Ile de la Réunion CHU sud
Saint-Pierre, 97448, France
-
Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard
Paris, 75018, France
-
Centre d'investigation clinique 1406 CHU Grenoble
Grenoble, 38043, France
-
Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou
Rennes, 35033, France
-
Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne
Dijon, 21 079, France
-
Département maladie infectieux CHU Saint Etienne
Saint-Etienne, 42055, France
-
Service de Maladies infectieuses et tropicales Centre hospitalier
Cayenne, 97306, French Guiana
-
Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon
Besançon, 25030, France
-
Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin
Bordeaux, 33076, France
-
Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital swab test tell COVID and flu apart at home?
- Sniffing your way back: does scent therapy rebuild COVID-Shattered smell?
- Experimental drug aims to tame severe COVID-19 inflammation
- Long-Term heart risks after rare COVID complication in kids under scrutiny
- Which COVID-19 shot causes fewer side effects? new study compares novavax and pfizer
- Scientists create COVID-19 biobank to unlock disease secrets